Clinical Trials
6 trialsNCT01042379 2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT06224673 2026-05-01
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
University of California, San Francisco
Phase 2 Not yet recruiting
NCT06578286 2024-08-29
ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd
Fudan University
Phase 2 Not yet recruiting
NCT04983121 2022-09-13
Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients
Shengjing Hospital
Phase 2 Recruiting
NCT05018702 2022-06-01
ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases
Fudan University
Phase 2 Unknown
NCT05018676 2022-04-25
ARX788 in Breast Cancer With Low Expression of HER2
Fudan University
Phase 2 Unknown